IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Doctor on how 'effective parenting' can support teens' mental health

    05:18
  • Pink Power: Products that support the fight against breast cancer

    04:22
  • Clea Shearer meets women from online cancer support group

    06:31
  • Elizabeth Holmes sentencing delayed amid bid for new trial

    00:26
  • Simple ways to add more happiness to your daily life

    04:33
  • Elizabeth Hurley talks Estée Lauder’s breast cancer campaign

    05:28
  • Jazz up your daily walks with these easy moves

    04:26
  • How to identify your breast cancer risk and steps to reduce it

    05:28
  • JJ Watt reveals he had heart 'shocked back into rhythm' Thursday

    01:23
  • How to join the Start TODAY Walking Club October challenge

    03:29
  • NFL fires one of the doctors who cleared Tua Tagovailoa to play

    02:01
  • NFL legend Terry Bradshaw reveals two cancer diagnoses

    00:49
  • Katie Couric says she was ‘stunned’ after breast cancer diagnosis

    11:20
  • NFLPA fires doctor who cleared Tua Tagovailoa to play after injury

    00:41
  • Why women need access to better breast cancer screenings

    04:54
  • Hospitals are evacuating patients after Hurricane Ian

    02:16
  • New ALS treatment approved by the FDA

    03:48
  • FDA approves new drug to slow progress of ALS

    00:24
  • Why flu shots are especially important this year

    01:55
  • How a unique home visit program is saving lives

    04:47

FDA approves first medical treatment for Alzheimer’s in 18 years

01:30

The drug aducanumab, developed by the company Biogen, attacks the amyloid protein that builds up in the brain of Alzheimer’s patients. The drug is going on the market even though the FDA says there are “uncertainties regarding clinical benefits” and is requiring Biogen to do another clinical trial.